Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 783
Index total 30,257
Page 18 / 33

Quick answer

This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

783 results for “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE” · 30,257 patents in full index Clear search

  1. US 8106026

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  2. US 8105609

    Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  3. US 8092809

    Pseudomonas exotoxin A-like chimeric immunogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  4. US 8084250

    Defensin-antigen fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted
  5. US 8084415

    Uteroglobin in the treatment of IGA mediated nephropathy

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted
  6. US 8080554

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  7. US 8075921

    Rapamycin-resistant T cells and therapeutic uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  8. US 8071323

    Human monoclonal antibodies that bind human insulin like growth factors and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  9. US 8067563

    Tumor suppressor gene, p471NG3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  10. US 8067202

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  11. US 8063209

    Phosphonyl ester conjugates as prodrugs

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted
  12. US 8058249

    Immunostimulatory nucleic acid molecules

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  13. US 8048432

    Polysaccharide-protein conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  14. US 8044057

    Methods for suppressing an immune response or treating a proliferative disorder

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  15. US 8043622

    Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  16. US 8043623

    Immunogenic peptides for the treatment of prostate and breast cancer

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  17. US 8044185

    Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  18. US 8038997

    Anti-marinobufagenin antibodies and methods for their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  19. US 8029788

    Variants of humanized anti-carcinoma MAb CC49

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  20. US 8030341

    Dmt-derivative compounds and related compositions and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  21. US 8030287

    DNA vaccine against North American spring viremia of carp virus

    The United States of America as represented by the Secretary of the Army · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted
  22. US 8026350

    Tumor suppressor gene, p28ING5

    The United States of America as represented by theDepartment of Health and Human Services · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted
  23. US 8021671

    Pro-apoptotic bacterial vaccines to enhance cellular immune responses

    The United States of America as represented by the Department of Veteran Affairs · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted
  24. US 8017578

    Orally active peptides that prevent cell damage and death

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted